Event Title

Exploring How the N152T Mutation in the Class C ²-lactamase, AmpC, can Serve as a Substrate Selectivity Switch

Presentation Type

Poster/Portfolio

Presenter Major(s)

Chemistry

Mentor Information

Brad Wallar

Department

Chemistry

Location

Henry Hall Atrium 25

Start Date

10-4-2013 12:00 PM

End Date

10-4-2013 1:00 PM

Keywords

Health, Life Science

Abstract

AmpC is a main cause of antibiotic resistance in some types of bacteria. While some active site residues' catalytic roles have been revealed, their contributions to which antibiotic they can inactivate is unknown. Prior work has shown that a mutation of a highly conserved residue in the active site (N152) can result in substrate selectivity changes in similar class C beta-lactamases. The role of the active site residue asparagine-152 (N152) mutated to threonine (T) allowed us to examine the kinetic and structural properties of this mutant with beta-lactam antibiotics. Although the N152T mutation caused a higher Km with all substrates, N152T exhibits over 150 fold higher kcat against cefotaxime. To investigate the mechanism of the observed change in selectivity, the X-ray crystal structure of AmpC N125T was determined. In comparison to the wild type AmpC structure, small structural active site differences have been associated with the changes in the kinetic values.

This document is currently not available here.

Share

COinS
 
Apr 10th, 12:00 PM Apr 10th, 1:00 PM

Exploring How the N152T Mutation in the Class C ²-lactamase, AmpC, can Serve as a Substrate Selectivity Switch

Henry Hall Atrium 25

AmpC is a main cause of antibiotic resistance in some types of bacteria. While some active site residues' catalytic roles have been revealed, their contributions to which antibiotic they can inactivate is unknown. Prior work has shown that a mutation of a highly conserved residue in the active site (N152) can result in substrate selectivity changes in similar class C beta-lactamases. The role of the active site residue asparagine-152 (N152) mutated to threonine (T) allowed us to examine the kinetic and structural properties of this mutant with beta-lactam antibiotics. Although the N152T mutation caused a higher Km with all substrates, N152T exhibits over 150 fold higher kcat against cefotaxime. To investigate the mechanism of the observed change in selectivity, the X-ray crystal structure of AmpC N125T was determined. In comparison to the wild type AmpC structure, small structural active site differences have been associated with the changes in the kinetic values.